BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
1.390
-0.090 (-6.08%)
Nov 21, 2024, 4:00 PM EST - Market closed
BioAtla Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 67 | 118 | 391 | 723 | 1,145 | - | |
Market Cap Growth | 4.68% | -69.81% | -45.97% | -36.84% | - | - | |
Enterprise Value | 16 | -21 | 217 | 453 | 1,188 | - | |
Last Close Price | 1.48 | 2.46 | 8.25 | 19.63 | 34.01 | - | |
PS Ratio | 6.48 | - | - | 2892.35 | 2668.76 | - | |
PB Ratio | 3.12 | 1.67 | 2.17 | 3.43 | 5.45 | - | |
P/TBV Ratio | 3.70 | 1.67 | 2.17 | 3.43 | 5.45 | - | |
EV/Sales Ratio | 1.48 | - | - | 1812.65 | 2768.30 | - | |
Debt / Equity Ratio | 0.05 | 0.03 | 0.02 | 0.03 | 0.00 | -0.32 | |
Asset Turnover | 0.10 | - | - | 0.00 | 0.00 | 0.40 | |
Quick Ratio | 2.90 | 3.93 | 9.32 | 12.36 | 7.40 | 0.14 | |
Current Ratio | 3.11 | 4.11 | 9.53 | 12.48 | 7.46 | 0.17 | |
Return on Equity (ROE) | -139.06% | -98.37% | -54.44% | -45.34% | -46.57% | - | |
Return on Assets (ROA) | -50.47% | -46.93% | -28.15% | -24.14% | -14.80% | -136.05% | |
Return on Capital (ROIC) | -88.52% | -62.97% | -33.75% | -28.24% | -21.78% | - | |
Earnings Yield | -123.54% | -104.70% | -27.26% | -13.19% | -3.13% | - | |
FCF Yield | -128.47% | -88.29% | -23.21% | -8.73% | -3.23% | - | |
Buyback Yield / Dilution | -3.25% | -22.74% | -12.63% | -310.07% | 84.56% | -1200.00% | |
Total Shareholder Return | -3.25% | -22.74% | -12.63% | -310.07% | 84.56% | -1200.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.